Suchergebnisse - "Cescon, David W."

PubPharm (153)

1

PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer

enthalten in: Nature communications | 2024

von Lin, C. | Chang, T. | Wang, Y. | +22

UpdateOf: Res Sq. 2023 Jul 10;:. - PMID 37502925

2

Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification

enthalten in: bioRxiv.org | 2024

von Zhang, C. | Wu, B. | Wu, Y. | +11

3

PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer

enthalten in: Radiation oncology (London, England) | 2024

von Pellizzari, S. | Bhat, V. | Athwal, H. | +3

4

PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer

enthalten in: Radiation oncology | 2024

von Pellizzari, S. | Bhat, V. | Athwal, H. | +3

5

Seize the engine : Emerging cell cycle targets in breast cancer

enthalten in: Clinical and translational medicine | 2024

von Fuentes-Antrás, J. | Bedard, P. | Cescon, D.

6

The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers

enthalten in: Cancers | 2024

von Kazandjian, S. | Rousselle, E. | Dankner, M. | +6

7

A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Cescon, D. | Hilton, J. | Morales Murilo, S. | +17

8

Seize the engine : Emerging cell cycle targets in breast cancer

enthalten in: Clinical and Translational Medicine | 2024

von Fuentes‐Antrás, J. | Bedard, P. | Cescon, D.

9

Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality

enthalten in: Cancer research | 2023

von Lin, P. | Lourenco, C. | Cruickshank, J. | +9

10

Health-Related Quality of Life With Pembrolizumab+Chemotherapy Versus Placebo+Chemotherapy for Advanced Triple-Negative Breast Cancer : KEYNOTE-355

enthalten in: Journal of the National Cancer Institute | 2023

von Cescon, D. | Schmid, P. | Rugo, H. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]